GlassScriptPhysician profile
Lucas Jacomides
NPI 1750381620
$20,758.49
in general payments reported to CMS, 2019-2025
44 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $337 · 2021: $673 · 2022: $780 · 2023: $985 · 2024: $1,086 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,387.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,000.00 | 2019 | |
| Boston Scientific Corporation | $943.77 | 2019-2025 | Tactra, Lithovue, Axonics |
| Coloplast Corp | $854.34 | 2019-2025 | Titan, Speedicath |
| Axonics, INC. | $791.65 | 2020-2024 | Axonics |
| Antares Pharma, INC. | $310.17 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Abbvie INC. | $298.99 | 2022-2025 | |
| Procept Biorobotics Corporation | $268.21 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Progenics Pharmaceuticals, INC. | $215.85 | 2023-2025 | Pylarify |
| Abbott Laboratories | $183.46 | 2023-2024 | Octrode |
| Urogen Pharma, INC. | $182.35 | 2022-2025 | |
| Allergan, INC. | $172.37 | 2020-2022 | |
| Pfizer INC. | $156.63 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $144.29 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $108.03 | 2019-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $102.87 | 2019-2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $101.52 | 2025 | Ecoin Device Kit |
| Edap Technomed INC | $83.33 | 2022 | |
| 180 Medical, INC. | $77.73 | 2022-2023 | |
| Bluewind Medical | $67.17 | 2024-2025 | Revi |
| Tolmar, INC. | $60.58 | 2023-2025 | Jatenzo |
| Olympus America INC. | $55.99 | 2023-2025 | Itind System, Soltive, Uretero-Reno Videoscope |
| Endo USA, INC. | $41.56 | 2025 | Aveed, Xiaflex |
| Kowa Pharmaceuticals America, INC. | $39.13 | 2022-2023 | Seglentis |
| Myovant Sciences INC. | $38.23 | 2021 | |
| Ethicon US, LLC | $33.40 | 2025 | Echelon Circular |
| Myriad Genetic Laboratories, INC. | $32.74 | 2021-2022 | |
| Smith+Nephew, INC. | $28.51 | 2022 | |
| Ferring Pharmaceuticals INC. | $28.03 | 2024 | Adstiladrin |
| Hollister Incorporated | $27.60 | 2021 | |
| Acerus Pharmaceuticals Corporation | $26.55 | 2020-2021 | |
| Angiodynamics, INC. | $26.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.41 | 2025 | |
| Lilly USA, LLC | $23.88 | 2025 | Zepbound |
| Travere Therapeutics, INC. | $23.42 | 2021 | |
| Accord Healthcare, INC. | $23.31 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $23.25 | 2023 | Lynparza |
| Halozyme INC | $23.20 | 2023 | |
| Cook Medical LLC | $18.43 | 2019 | |
| Millicent US INC | $18.03 | 2024 | Intrarosa |
| Caldera Medical, INC | $17.86 | 2025 | |
| Teleflex LLC | $15.60 | 2023 | Urolift |
| Novartis Pharmaceuticals Corporation | $15.25 | 2024 | |
| Becton, Dickinson and Company | $14.86 | 2024 | Bard Urinary Drainage Bag |
| Neotract INC. | $14.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Jacomides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.